AZ sues Watson to stop copycat Crestor; Erbitux study raises KRAS questions;

@FiercePharma: NICE to be sidelined, minister confirms. Report | Follow @FiercePharma

> AstraZeneca has sued Watson Pharmaceuticals to block the launch of a generic version of Crestor, a cholesterol-lowering medicine and the company's top seller. Report

> Eli Lilly and Merck KGaA's Erbitux helped a group of cancer patients thought to be immune to the treatment in a study that contradicts earlier assumptions of the way the drug works in those with a genetic mutation. News

> The Australian Competition and Consumer Commission postponed its decision on whether to allow a bid by Aspen Pharmacare for Sigma Pharmaceuticals' generic drugs division. Item

> PhRMA says a new Puerto Rico law to tax offshore manufacturers will "dramatically hinder" biopharma companies. Article

> Attorneys general in Illinois, Oregon and California said on Tuesday that Bayer agreed to a $3.3 million settlement over misleading claims that the drugmaker's vitamins reduced men's risk of prostate cancer. News

> Abbott Laboratories sued generics maker Anchen Pharmaceuticals in federal court in Delaware for infringing a U.S. patent for the kidney drug Zemplar. Story

Biotech News

 @FierceBiotech: Analysts take on obesity drugs turns grim after lorcaserin CRL. Report | Follow @FierceBiotech

  @JohnCFierce: Rodman & Renshaw analyst Elemer Piros on the future of obesity drugs: "This whole space is pretty much dead." News | Follow @JohnCFierce

> Corengi tech could enlarge pool of trial subjects. Report

> Bonfiglio named president, CEO of Transdel. News 

> Myriad gains from Abbott testing deal. Story

> Index founds Mind-NRG with $13.8M investment. Article 

> PacBio raises $200M with IPO. News

Drug Delivery News

> Highland looks for partners for abuse-resistant prescriptions. Story 

> NCI rewards DNA/RNA nanomotor work with $2.5M. Item 

> 'Stapled peptides' still the talk of the town. Report 

> Chinese microneedle company wins Silver from WSJ. Story. Article

> Georgia Tech, Emory use NCI grants, nanoparticles to target cancers. News 

> DIY drug administration on rise. Story

Medical Devices News

> Edwards, Hospira, KCI discuss Q3 results. Story

> ExonHit backs out of $22.5M RedPath buyout. Item

> How safe are endoscopies? Report

> Boston Sci looks at more acquisitions as Asthmatx deal closes. Article 

> Can brain signals can control prosthetic arms? Story

> SpectraScience announces strategic restructuring. News 

And Finally... It could be selling season for pharmacy benefit managers, with Walgreen and Cigna rumored to be selling their PBM units. Report